The presence of CDH1 epigenetic and structural alterations in a diagnostic/pre‐operative biopsy may provide clinically useful information to improve patient management, particularly to infer the prognosis of breast cancer and the pattern of tumour dissemination. Here, CDH1 is linked to neoplasm.